Questions for Investor & Analyst Meeting are being requested on Star's website.
Please "send your question to: questions@starscientific.com".
My question: Has Star given consideration to an anatabine e-cigarette? Any details?
If we also put our questions on this website, we'll have an idea of how open management is to helping us place a value on the company. If we have LOTS of questions, but Star gives us 15 minutes of boilerplate, and says everything else is confidential, well…..
And the company filed its 10-K with 5 minutes left of trading today, just the way the big boys play.
from 10-k news release: "On March 12, 2014, the Company entered into a series of financing transactions that resulted in gross cash proceeds of approximately $9.3 million and cash availability under a credit facility of approximately $5.8 million (subject to certain conditions and limitations), for total available funds of $15.1 million. This financing is intended to provide support for the Company's ongoing operations, including its plans to file an Investigational New Drug Application ("IND") during the second quarter 2014 and, if permitted by the FDA, to begin a Phase I clinical trial thereafter directed to a specific disease condition."
